Related Experiment Video
Updated: Mar 15, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
The Clinical Significance of SPOP Upregulation and Nuclear Accumulation in Head and Neck Squamous Cell Carcinoma
Yin-Hwa Shih1, Nan-Chin Lin2, Yen-Wen Shen3
1Department of Healthcare Administration, Asia University, Taichung 41354, Taiwan.
Abstract:
The speckle-type BTB/POZ protein (SPOP) is an E3 ubiquitin ligase adaptor typically considered a tumor suppressor, yet its role in head and neck squamous cell carcinoma (HNSCC) remains unclear. This study investigated SPOP expression, arecoline regulation, and its potential as a HNSCC biomarker. SPOP mRNA and its protein were quantified in HNSCC (FaDu, GMN, HSC-3, SAS, and A253) and normal oral epithelial (SG) cell lines via RT-qPCR and Western blot; arecoline's effect on SG, SAS, and A253 cells was evaluated. SPOP mRNA was analyzed using The Cancer Genome Atlas (TCGA) HNSCC cohort, and protein localization was assessed via immunohistochemistry (IHC) on tissue microarrays. SPOP mRNA was higher in some HNSCC lines; arecoline induced SPOP in SG cells, but not in HNSCC cell lines. TCGA confirmed SPOP mRNA upregulation in tumors correlating with grade. IHC showed SPOP upregulation in HNSCC, particularly in palate and pharynx/hypopharynx sites. The nuclear SPOP-positive ratio shifted from 12.14 ± 9.82% in normal tissues to 61.26 ± 33.03% in tumors (p < 0.0001), differentiating grades and sites better than total expression. SPOP is upregulated in HNSCC and inducible by arecoline. Enhanced nuclear SPOP localization indicates malignancy and progression, identifying it as a potential HNSCC diagnostic and progression biomarker.
Insights
Speckle-type BTB/POZ protein (SPOP) is upregulated in head and neck squamous cell carcinoma (HNSCC). Increased nuclear SPOP indicates malignancy and progression, suggesting its potential as an HNSCC biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The role of Speckle-type BTB/POZ protein (SPOP), an E3 ubiquitin ligase adaptor, in head and neck squamous cell carcinoma (HNSCC) is not well understood.
- While generally considered a tumor suppressor, SPOP's specific function in HNSCC warrants investigation.
Purpose of the Study:
- To investigate SPOP expression levels and regulation by arecoline in HNSCC.
- To evaluate the potential of SPOP as a diagnostic and progression biomarker for HNSCC.
Main Methods:
- Quantification of SPOP mRNA and protein in HNSCC and normal oral epithelial cell lines using RT-qPCR and Western blot.
- Assessment of arecoline's effect on SPOP expression in selected cell lines.
- Analysis of SPOP mRNA in the TCGA HNSCC cohort and protein localization via immunohistochemistry on tissue microarrays.
Main Results:
- SPOP mRNA was found to be higher in some HNSCC cell lines compared to normal cells.
- Arecoline induced SPOP expression in normal oral epithelial cells but not in HNSCC cell lines.
- TCGA data confirmed SPOP mRNA upregulation in HNSCC tumors, correlating with tumor grade.
- Immunohistochemistry revealed SPOP upregulation in HNSCC tissues, particularly in palate and pharynx/hypopharynx.
- A significant shift in nuclear SPOP-positive ratio from normal tissues (12.14%) to tumors (61.26%) was observed, differentiating grades and sites effectively.
Conclusions:
- SPOP is upregulated in HNSCC and its expression can be induced by arecoline.
- Enhanced nuclear localization of SPOP is indicative of malignancy and disease progression in HNSCC.
- SPOP demonstrates potential as a valuable diagnostic and progression biomarker for HNSCC.
Related Concept Videos
Abnormal Proliferation
Regulation of Nuclear Protein Sorting
Induced Pluripotent Stem Cells
Somatic...
The Nucleolus

